1. Home
  2. PACB vs JPI Comparison

PACB vs JPI Comparison

Compare PACB & JPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • JPI
  • Stock Information
  • Founded
  • PACB 2000
  • JPI 2012
  • Country
  • PACB United States
  • JPI United States
  • Employees
  • PACB N/A
  • JPI N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • JPI Finance Companies
  • Sector
  • PACB Industrials
  • JPI Finance
  • Exchange
  • PACB Nasdaq
  • JPI Nasdaq
  • Market Cap
  • PACB 364.2M
  • JPI 297.1M
  • IPO Year
  • PACB 2010
  • JPI N/A
  • Fundamental
  • Price
  • PACB $1.00
  • JPI $20.12
  • Analyst Decision
  • PACB Buy
  • JPI
  • Analyst Count
  • PACB 9
  • JPI 0
  • Target Price
  • PACB $2.34
  • JPI N/A
  • AVG Volume (30 Days)
  • PACB 9.9M
  • JPI 54.7K
  • Earning Date
  • PACB 05-08-2025
  • JPI 01-01-0001
  • Dividend Yield
  • PACB N/A
  • JPI 6.15%
  • EPS Growth
  • PACB N/A
  • JPI N/A
  • EPS
  • PACB N/A
  • JPI N/A
  • Revenue
  • PACB $152,357,000.00
  • JPI N/A
  • Revenue This Year
  • PACB $4.67
  • JPI N/A
  • Revenue Next Year
  • PACB $19.09
  • JPI N/A
  • P/E Ratio
  • PACB N/A
  • JPI N/A
  • Revenue Growth
  • PACB N/A
  • JPI N/A
  • 52 Week Low
  • PACB $0.85
  • JPI $16.02
  • 52 Week High
  • PACB $2.72
  • JPI $19.12
  • Technical
  • Relative Strength Index (RSI)
  • PACB 41.44
  • JPI 53.58
  • Support Level
  • PACB $0.85
  • JPI $19.87
  • Resistance Level
  • PACB $1.15
  • JPI $20.40
  • Average True Range (ATR)
  • PACB 0.08
  • JPI 0.31
  • MACD
  • PACB 0.00
  • JPI -0.08
  • Stochastic Oscillator
  • PACB 38.07
  • JPI 34.59

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About JPI Nuveen Preferred and Income Term Fund of Beneficial Interest

Nuveen Preferred and Income Term Fund is a closed-end management investment company. Its investment objective is to provide a high level of current income and total return. The company's products include mutual funds, closed-end funds, Exchange-traded funds, Multi-asset model portfolios, and others.

Share on Social Networks: